Colgate-Palmolive shares have gained 12% year-to-date, supported by strong Q1 2026 earnings beating expectations and accelerating organic sales growth, especially in emerging markets. The company’s restructuring program aims to save $200-$300 million annually to boost advertising and margins once tariff pressures ease. Despite tariff-related margin risks and a goodwill impairment in China, the stock offers downside protection with a low beta and a 63-year dividend increase streak. Analysts set a 12-month price target of $103.17, implying an 18% upside, with a bullish scenario reaching $107.54 and a conservative floor at $92.10. Investors should watch tariff developments and North American sales trends going forward.
